awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42710884-573E1674-40AA-41F2-A685-E9A59AEDE732
Q42710884-573E1674-40AA-41F2-A685-E9A59AEDE732
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42710884-573E1674-40AA-41F2-A685-E9A59AEDE732
Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment.
P2860
Q42710884-573E1674-40AA-41F2-A685-E9A59AEDE732
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42710884-573E1674-40AA-41F2-A685-E9A59AEDE732
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
585930c36dbc96b9a5aeef0b98ee1c26d88aac30
P2860
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.